Can You Get Pregnant With Cushing’s Disease?

Getting pregnant with active Cushing’s disease is possible but unlikely. The excess cortisol and androgens produced by the condition directly interfere with ovulation, making natural conception rare while the disease is untreated. In one study of 70 women of reproductive age with Cushing’s disease, there were zero cases of conception occurring after the disease was already active. However, pregnancy can and does occur in some cases, particularly when symptoms are mild or when treatment has brought cortisol levels under control.

How Cushing’s Disease Disrupts Fertility

Your reproductive system depends on a tightly regulated hormonal chain. The brain releases a signaling hormone called GnRH in precise pulses, which tells the pituitary gland to produce the hormones that trigger ovulation each month. In Cushing’s disease, chronically elevated cortisol and androgens suppress those GnRH pulses. Without the right signal, your ovaries don’t release eggs on a normal schedule, or may stop releasing them altogether.

This is why many women with active Cushing’s experience irregular or absent periods well before they receive a diagnosis. The menstrual disruption isn’t a side effect of feeling unwell. It’s a direct result of cortisol flooding the hormonal pathway that controls your cycle.

When Pregnancy Does Happen

Though uncommon, pregnancy during active Cushing’s disease is not unheard of. The relationship between the two conditions often runs in the other direction: pregnancy itself may trigger or unmask Cushing’s disease. In a retrospective study of 70 women with Cushing’s, about 27% had what researchers classified as “pregnancy-associated” Cushing’s disease, meaning the condition appeared during pregnancy or within 12 months of delivery. Of those 19 pregnancies, 14 resulted in live births, while five ended in spontaneous miscarriage.

Notably, 70% of the women in that study had at least one pregnancy before Cushing’s disease developed. This fits the broader pattern: conception typically happens before the disease takes hold, not after.

Risks for Mother and Baby

When pregnancy does overlap with active Cushing’s, both the mother and baby face elevated risks. Prolonged exposure to high cortisol can cause gestational diabetes, high blood pressure, dangerously low potassium, heart failure, pulmonary edema, serious infections, and bone fractures in the mother. Complicating matters, many of these symptoms overlap with common pregnancy conditions like preeclampsia and gestational diabetes, which can delay a correct diagnosis.

Fetal complications are also significant. The most common is premature birth, occurring in roughly 43% of affected pregnancies. Intrauterine growth restriction, where the baby doesn’t grow at the expected rate, happens in about 21% of cases. Stillbirth occurs in approximately 6% of pregnancies complicated by Cushing’s, and spontaneous miscarriage or intrauterine death accounts for another 5%. These numbers underscore why managing cortisol levels during pregnancy is a priority.

Diagnosing Cushing’s During Pregnancy

Diagnosing Cushing’s disease is already tricky. It becomes harder during pregnancy because cortisol naturally rises throughout gestation. Many of the standard screening tests lose their reliability when a woman is pregnant. However, late-night salivary cortisol testing has shown high sensitivity and specificity across all three trimesters when pregnancy-specific cutoff values are used. This makes it one of the more reliable tools for distinguishing between the normal cortisol rise of pregnancy and the pathological excess of Cushing’s disease.

Managing Cushing’s Disease During Pregnancy

Treatment depends on how severe the cortisol excess is and how far along the pregnancy has progressed. The options fall into two categories: medication to lower cortisol, and surgery to remove the pituitary tumor causing the problem.

Medication

The most commonly used medication during pregnancy is metyrapone, a drug that blocks cortisol production. It has been used safely in pregnant patients, and in documented cases, fetal growth and well-being remained normal throughout treatment. In one detailed case, a baby was born at 35 weeks weighing 2.41 kg with excellent health scores and no complications, though the infant’s cortisol was temporarily low on the first day of life. This confirmed that metyrapone does cross the placenta and can suppress cortisol production in the fetus, but without necessarily causing clinical problems.

Ketoconazole, another cortisol-lowering drug sometimes used outside of pregnancy, is generally avoided because of its potential to interfere with fetal genital development. In the rare cases where it has been used, doctors typically discontinue it as soon as pregnancy is confirmed.

Surgery

When medication alone isn’t sufficient, surgery to remove the pituitary tumor through the nose (transsphenoidal surgery) can be performed during pregnancy. The second trimester is considered the safest window. In a review of surgical cases, nearly 56% of patients had their procedure during the second trimester, and outcomes for both mother and baby were generally favorable. Surgery during the first trimester is typically postponed if possible. Across all cases reviewed, about 63% of patients achieved full hormonal remission after surgery.

Fertility After Treatment

The encouraging reality is that once Cushing’s disease is successfully treated and cortisol levels return to normal, the hormonal chain controlling ovulation typically recovers. Many women who were unable to conceive during active disease go on to have healthy pregnancies after treatment. The timeline for recovery varies. Some women see their menstrual cycles normalize within a few months of remission, while others may take longer, particularly if the disease was severe or long-standing.

If you have Cushing’s disease and want to become pregnant, the most reliable path is treating the underlying condition first. Bringing cortisol levels into a normal range restores ovulation in most cases and dramatically reduces the maternal and fetal risks that come with an uncontrolled pregnancy.